ESR1 and prostate neoplasm: Unlike other ER ligands, we found that αE2 was able to specifically induce growth of HAECs, while it blocked DHT-induced prostate tumor cell proliferation and inhibited tumor growth in prostate cancer xenograft mice (5,7,24).